Hybrid GEoPD Meeting, hosted by Karolinska Institutet
The 17th International Meeting is scheduled on November 20^th -22^nd.
The event has started on Sunday November 20, 2022 (GEoPD members only) with the below activities: 

• 16:00 Sightseeing tour in Gamla stana
• 18:00 Welcoming cocktail
• 19:30 Meeting of the GEoPD steering committee

 The event is endorsed by the International Parkinson and Movement Disorder Society

1. 21 Nov

   Monday November 21, 2022 (GEoPD members only)

   08:00	Registration
   08:30	Introduction, membership updates	Katerina Markopoulou, President
   	Ongoing projects session (reports from ongoing GEoPD projects)
   08:50	Monogenic PD	Christine Klein
   09:20	LONG-PD	Katerina Markopoulou
   09:50	Courage PD	Manu Sharma
   10:20	Functional validation of polygenic risk scores	Rejko Krueger
   10:50	Coffee break
   	Datablitz session (presentation 10 minutes, questions 5 minutes, for each member site)
   11:20	Session 1
   12:30	Lunch and posters
   13:30	Session 2
   15:30	Coffee break
   	New Projects
   16:00	Discussion on new projects
   17:00	Closing remarks
   19:00	Dinner at Svarta Räfven
   		GEoPD members only

2. 22 NOV

   Tuesday November 22, 2022 (Open symposium)

   08:15	Opening Remarks	Karin Wirdefeldt
   08:30	Presentation in memory of GEoPD Steering Committee member, Stefano Duga (virtual)	Rosanna Asselta
   08:40	Presentation in memory of GEoPD Steering Committee member, Jan Aasley	Matt Farrer
   	Pathogenesis of Parkinson’s Disease
   09:00	Update on Monogenic GP2 network (virtual)	Christine Klein (virtual)
   09:40	Update on GP2 Complex network (virtual)	Huw Morris
   10:20	Coffee break
   	Connectomics in PD
   10:50	An agent-based Propagation Model of Parkinson’s Disease	Alain Dagher
   11:30	Functional Connectivity in Parkinson’s Disease	Massimo Filippi (virtual)
   12:10	Lunch
   	Afternoon session Deep brain stimulation (DBS) genetics
   13:15	Swedish Patients with Gaucher´s Disease and GBA-Parkinsonism	Per Svenningsson
   13:55	Should we offer Deep Brain Stimulation to GBA-PD patients?	Carlo Alberto Artusi
   14:35	Coffee break
   15:05	Response to DBS in patients with monogenic PD and GBA mutation carrier	Jean-Christophe Corvol
   	Genetically stratified treatments for PD and Digital Biomarkers in PD
   15:50	Results of the Prasinezumab study	Gennaro Pagano
   16:30	Digital biomarkers in PD	Cristina Simonet
   17:10	A review of Genetics in Subthalamic Nucleus DBS	Katerina Markopoulou
   17:50	Closing remarks	Karin Wirdefeldt and Katerina Markopoulou
   		Public meeting